| Value | ₹6.34 Cr |
|---|---|
| Execution period | 60 days |
BSE filing, NSE: VALIANTORG. Summary written from the filing by ALFA Finder's alert engine.
Valiant Organics Ltd: key numbers
- Share price
- ₹456.20
- Market cap
- ₹1,279 Cr
- Revenue (annual)
- ₹738.8 Cr
- Net profit (annual)
- ₹33.24 Cr
- P/E (TTM)
- 23.6×Sector 34.1×
- Promoter holding
- 37.89%+0.02% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valiant Organics Ltd
All →Valiant Organics Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Valiant Organics Legal & Regulatory
Valiant Organics received an income tax rectification order for Assessment Year 2015-16, determining a net payable amount of ₹0.22 Crore.
- Value
- ₹0.22 Cr
Valiant Organics Investor Presentation: Key Takeaways
Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.
Valiant Organics Annual General Meeting
Valiant Organics held its 21st AGM on September 29, 2026, transacting various ordinary and special business items including re-appointments and material related party transaction approvals.
Valiant Organics Promoter Buying: ₹0 Cr
Promoter Vicky Hemchand Gala purchased 3,500 shares of Valiant Organics via a market transaction. This increases the promoter's stake by 0.01%.
- Value
- ₹0.00 Cr
- Promoter stake change
- +0.01%
Valiant Organics Promoter Buying: ₹0.13 Cr
Promoter Vicky Hemchand Gala acquired 3,500 shares of Valiant Organics Ltd via a market purchase. This increases the promoter's holding from 0.92% to 0.93%.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.01%
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.